Study on the Medication Rules of Traditional Chinese Medicine (TCM) in Treating Hepatitis B Cirrhosis in the Compensated Stage Based on Data Mining
DOI:
https://doi.org/10.53469/jcmp.2025.07(03).01Keywords:
Traditional Chinese Medicine, Hepatitis B Cirrhosis Compensated Stage, Accumulation and Aggregation, Medication RulesAbstract
Objective: To apply data mining techniques to study the medication rules of Traditional Chinese Medicine (TCM) in the treatment of compensated hepatitis B cirrhosis. This research aims to provide clinical insights for the further development of TCM treatment for compensated hepatitis B cirrhosis. Methods: Using the keywords “hepatitis B cirrhosis compensated stage,” “liver involvement,” and “Traditional Chinese Medicine,” searches were conducted on platforms such as CNKI and Wanfang Database. Articles published from January 2008 to 2023 related to the compensated stage of liver cirrhosis were selected to create a database. The included TCM prescriptions were then analyzed for frequency, association rules, and clustering using software tools like Excel 2021, SPSS Modeler 18, and SPSS 26.0. Results: A total of 44 prescriptions comprising 158 herbal medicines were selected. The five most frequently used herbs were Fuling (Poria), Danshen (Salvia miltiorrhiza), Chaihu (Bupleurum), Baishao (Paeonia lactiflora), and Baizhu (Atractylodes macrocephala). Conclusion: This study summarizes the medication rules for the treatment of compensated hepatitis B cirrhosis, aiming to standardize clinical medication practices.
References
Zhang Huan. Summarize the rule of differentiation and treatment of compensatory hepatitis B cirrhosis with traditional Chinese medicine through digging clinical medical records [D]. Shangdong University of Traditional Chinese Medicine, 2023.
Yu Youxin; Tie Shenghua; Chen Siqing; Lan Ping. A discussion on the syndrome differentiation and treatment of hepatitis B cirrhosis in decompensated period [J]. Clinical Journal Of Chinese Medicine, 2023, 15(28): 122-125.
Wang Lianying. The study of medication on rule of Professor Zhang Junchang based on data mining in the treatment of Hepatitis B cirrhosis compensation period [D]. Guangzhou University of Traditional Chinese Medicine, 2019.
Zhang Jiazeng. Clinical Study of Jiawei Xia Yu Xue Formula Combined with the Blood Pricking Therapy in the Treatment of Hepatitis B Cirrhosis in Compensated Stage (Blood Stasis Blocking Collateral Type) [D]. Guangxi University of Traditional Chinese Medicine, 2023.
Zhang Xu. Clinical study of Jiawei Gexia Zhuyu Granule in the treatment of hepatitis B cirrhosis in compensated stage (blood stasis blocking collateral type) [D]. Guangxi University of Traditional Chinese Medicine,2022.
Wei Cuiting. Clinical research of Chaihu Guizhi Ganjiang Decoction and Danggui Shaoyao Decoction in thetreatment of hepatitis B liver cirrhosis in the compensatory phase [D]. Guangxi University of Traditional Chinese Medicine,2022.
Zhu Qianxin; He Jingsong; Li Mingshun; Zhong Peiling; Chen Yingjie. Clinical Study on Ruangan Granules Combined with Entecavir for Treatment of Active Compensation Period of Hepatitis B Cirrhosis[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2020,37(06):1024-1029.
Zhang Jialing. The clinical study of Rougan Sanjie Pills combined with Entecavir in the treatment of hepatitis B liver cirrhosis in the compensatory phase (blood stagnation syndrome) [D]. Guangxi University of Traditional Chinese Medicine, 2021.
Peng Mengnan. Clinical Study of Integrated Traditional Chinese and Western Medicine in The Treatment of Compensated Hepatitis B Cirrhosis Based on “Liver and Spleen Related” Theory. [D]. Guangzhou University of Traditional Chinese Medicine, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jialin Chang, Xuelian Dong
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
